Terapia Celular
![Foto de Terapia Celular](/img/uploaded/BC19F151D080465FBBDA9A5BB7348092.png)
![Foto de Hospital Universitario de Salamanca](/img/noimage_org.png)
Hospital Universitario de Salamanca
Salamanca, EspañaHospital Universitario de Salamanca -ko ikertzaileekin lankidetzan egindako argitalpenak (7)
2021
-
Long-term efficacy of autologous bone marrow mesenchymal stromal cells for treatment of knee osteoarthritis
Journal of Translational Medicine
2009
-
Prospective comparative analysis of the angiogenic capacity of monocytes and CD1331 cells in a murine model of hind limb ischemia
Cytotherapy, Vol. 11, Núm. 8, pp. 1041-1051
2007
-
In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression
Transfusion and Apheresis Science, Vol. 37, Núm. 2, pp. 145-156
-
Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers
Cytotherapy, Vol. 9, Núm. 1, pp. 14-22
2005
-
Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors
Haematologica, Vol. 90, Núm. 3, pp. 353-359
-
Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability
Experimental Hematology, Vol. 33, Núm. 8, pp. 935-943
2004
-
Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation
Haematologica, Vol. 89, Núm. 12, pp. 1421-1427